119 related articles for article (PubMed ID: 15289786)
41. [Pharmacogenetics: current state after 30 years of research].
Eichelbaum M
Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369
[No Abstract] [Full Text] [Related]
42. Does the CYP3A5*3 polymorphism affect in vivo drug elimination?
Thummel KE
Pharmacogenetics; 2003 Oct; 13(10):585-7. PubMed ID: 14515056
[No Abstract] [Full Text] [Related]
43. Practical considerations for pharmacogenetic testing.
Wedlund PJ
MLO Med Lab Obs; 2001 Sep; 33(9):16-21, 23; quiz 24-5. PubMed ID: 11569125
[No Abstract] [Full Text] [Related]
44. [Pharmacogenetics in pediatrics].
Aigrain EJ
Arch Pediatr; 2000 May; 7 Suppl 2():365s-367s. PubMed ID: 10904775
[No Abstract] [Full Text] [Related]
45. [Pharmacogenetics or "farm-ecogenetics"?].
Gérard N; Elion J; Krishnamoorthy R
J Soc Biol; 2000; 194(1):9-13. PubMed ID: 11107543
[TBL] [Abstract][Full Text] [Related]
46. Cytochrome P450 reconstitution systems.
Shimada T; Yamazaki H
Methods Mol Biol; 1998; 107():85-93. PubMed ID: 14577215
[No Abstract] [Full Text] [Related]
47. Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.
Smith T; Sharp S; Manzardo AM; Butler MG
Int J Mol Sci; 2015 Feb; 16(3):4416-28. PubMed ID: 25710722
[TBL] [Abstract][Full Text] [Related]
48. Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.
Wang HH; Liao YW; Chiang HL; Wu JY; Chen YT
Pharmacogenomics; 2009 Mar; 10(3):359-74. PubMed ID: 19290787
[TBL] [Abstract][Full Text] [Related]
49. Principles of pharmacogenetics--implications for the anaesthetist.
Iohom G; Fitzgerald D; Cunningham AJ
Br J Anaesth; 2004 Sep; 93(3):440-50. PubMed ID: 15220176
[No Abstract] [Full Text] [Related]
50. [Genetic polymorphism of cytochrome P450II E1 related to the development of nonalcoholic fatty liver].
Li JT; Zhao HC
Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):116. PubMed ID: 12648416
[No Abstract] [Full Text] [Related]
51. Analysis of cytochrome P450 polymorphisms.
Daly AK; Monkman SC; Smart J; Steward A; Cholerton S
Methods Mol Biol; 1998; 107():405-22. PubMed ID: 14577249
[No Abstract] [Full Text] [Related]
52. [Genetic tests give the finishing touch to individual drug dosage].
Sjöqvist F
Lakartidningen; 2003 Feb; 100(8):592-3. PubMed ID: 12640970
[No Abstract] [Full Text] [Related]
53. P450 enzymes and Parkinson's disease.
Le Couteur DG; McCann SJ
Mov Disord; 1998 Sep; 13(5):851-2. PubMed ID: 9756162
[No Abstract] [Full Text] [Related]
54. A DNA tragedy.
Stipp D
Fortune; 2000 Oct; 142(10):170-4, 178, 180 passim. PubMed ID: 11184820
[No Abstract] [Full Text] [Related]
55. Cytochrome P450: evolution and functional diversity.
Nebert DW; McKinnon RA
Prog Liver Dis; 1994; 12():63-97. PubMed ID: 7746878
[No Abstract] [Full Text] [Related]
56. [Comments to the brochure "Genetic tests and drug monitoring" distributed by the Laboratoriet, Epilepsihospitalet in Dianalund].
Línnet K
Ugeskr Laeger; 2004 Jan; 166(1-2):70-1; author reply 71. PubMed ID: 14752999
[No Abstract] [Full Text] [Related]
57. Analysis of polymorphic variation in drug metabolism: II. Effects of data transformation on the sensitivity and specificity of modal detection.
Herman RJ; Szakas CB; Verbeeck RK
Clin Invest Med; 1994 Aug; 17(4):290-6. PubMed ID: 7982292
[TBL] [Abstract][Full Text] [Related]
58. Analgesic prescribing.
Kuebler K
Am J Nurs; 2003 Jan; 103(1):16; author reply 16. PubMed ID: 12549473
[No Abstract] [Full Text] [Related]
59. Personalized drug therapy with pharmacogenetics. Part 1: Pharmacokinetics.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2006 Jan; 44(1):13-6. PubMed ID: 16475439
[No Abstract] [Full Text] [Related]
60. [Collection of familial data in pharmacogenetics. Methodological problems].
Poisson N; Bechtel Y; De La Selle P; Cormier S; Auziere C; Laurent P; Beaune P; Bignon J; Bechtel P; Feingold J
Therapie; 1993; 48(1):51-4. PubMed ID: 8356546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
